139 related articles for article (PubMed ID: 10223377)
21. Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
Chong SK; Lou Q; Asnicar MA; Zimmerman SE; Croffie JM; Lee CH; Fitzgerald JF
Pediatrics; 1995 Aug; 96(2 Pt 1):211-5. PubMed ID: 7630671
[TBL] [Abstract][Full Text] [Related]
22. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
[TBL] [Abstract][Full Text] [Related]
23. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease.
Kato S; Nishino Y; Ozawa K; Konno M; Maisawa S; Toyoda S; Tajiri H; Ida S; Fujisawa T; Iinuma K
J Gastroenterol; 2004 Aug; 39(8):734-8. PubMed ID: 15338366
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa.
Laine L
Gastroenterol Clin North Am; 1993 Mar; 22(1):117-25. PubMed ID: 8449561
[TBL] [Abstract][Full Text] [Related]
26. Effect of omeprazole and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the healing of duodenal ulcer: comparison with a historical control.
Schütze K; Hentschel E; Hirschl AM
Hepatogastroenterology; 1999; 46(28):2358-62. PubMed ID: 10521998
[TBL] [Abstract][Full Text] [Related]
27. Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
Gabryelewicz A; Laszewicz W; Dzieniszewski J; Ciok J; Marlicz K; Bielecki D; Popiela T; Legutko J; Knapik Z; Poniewierka E
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():93-105. PubMed ID: 9440060
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Helicobacter pylori in NSAID users with gastric ulcer.
Matsukawa Y; Aoki M; Nishinarita S; Sawada S; Horie T; Kato K; Kawamura Y; Kawamura F; Arakawa Y; Kurosaka H; Morita K; Ohtsuka E; Oribe M; Nakano M; Kitami Y
Rheumatology (Oxford); 2003 Aug; 42(8):947-50. PubMed ID: 12730504
[TBL] [Abstract][Full Text] [Related]
30. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
Publig W; Wüstinger C; Zandl C
Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
[TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.
Veldhuyzen van Zanten SJ; Sherman PM
CMAJ; 1994 Jan; 150(2):177-85. PubMed ID: 8287340
[TBL] [Abstract][Full Text] [Related]
32. Ulcers and gastritis.
Tytgat GN
Endoscopy; 2000 Feb; 32(2):108-17. PubMed ID: 10696838
[TBL] [Abstract][Full Text] [Related]
33. Helicobacter heilmannii gastritis: association with acid peptic diseases and comparison with Helicobacter pylori gastritis.
Jhala D; Jhala N; Lechago J; Haber M
Mod Pathol; 1999 May; 12(5):534-8. PubMed ID: 10349993
[TBL] [Abstract][Full Text] [Related]
34. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
36. [Helicobacter pylori and chronic gastritis: relationship between infection and inflammatory activity in a high risk population for gastric cancer].
Araya JC; Villaseca MA; Roa I; Roa JC
Rev Med Chil; 2000 Mar; 128(3):259-65. PubMed ID: 10962866
[TBL] [Abstract][Full Text] [Related]
37. [Standarts for diagnosis and treatment of acid and associated with Helicobacter pylori disease (the Fourth Moscow Agreement)].
Gastroenterological Scientific Society of Russia
Eksp Klin Gastroenterol; 2010; (5):113-8. PubMed ID: 20731141
[No Abstract] [Full Text] [Related]
38. Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
Hawkey CJ; Naesdal J; Wilson I; Långström G; Swannell AJ; Peacock RA; Yeomans ND
Gut; 2002 Sep; 51(3):336-43. PubMed ID: 12171953
[TBL] [Abstract][Full Text] [Related]
39. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
Graham DY
Helicobacter; 2002 Feb; 7(1):1-8. PubMed ID: 11886469
[TBL] [Abstract][Full Text] [Related]
40. Novel therapeutic approaches to gastric and duodenal ulcers: an update.
Dajani EZ; Klamut MJ
Expert Opin Investig Drugs; 2000 Jul; 9(7):1537-44. PubMed ID: 11060758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
